Premium
West Pharmaceutical Services Inc (W2ST34)
BOV
Hot Features
Inscrivez-vous pour des graphiques en temps réel, des outils d'analyse et des prix.
| Date | Nom du détenteur | Actions transigées | Fourchette de valeur ($) | Type d'opération | Fourchette de prix ($) | Actions en fin de déclaration | % de variation |
|---|---|---|---|---|---|---|---|
| 2026-05-12 | Mr. Shane A. CampbellSVP & Chief Proprietary Segment Officer | 550,33 | 0,00 | Derivative Exercise and Retained Stock | - | 613,00 | 878,17% |
| 2026-05-12 | Mr. Shane A. CampbellSVP & Chief Proprietary Segment Officer | -219,26 | 68,42k | Derivative Exercise and Sale | 312,07 | 613,00 | - |
| 2026-04-27 | Ms. Annette F. FavoriteChief HR Officer & Senior VP | -2,82k | 624,62k | Derivative Exercise and Sale | 83,47 - 305,20 | 16,83k | - |
| 2026-04-27 | Mr. Chad R. WintersVP of Finance & CAO | -896,00 | 114,19k | Derivative Exercise and Sale | 173,22 - 300,67 | 1,52k | - |
| 2026-02-20 | Mr. Rudy J. PoussotSVP of Strategy & Corporate Development | 253,84 | 0,00 | Derivative Exercise and Retained Stock | - | 561,00 | 82,64% |
| 2026-02-20 | Mr. Rudy J. PoussotSVP of Strategy & Corporate Development | -129,55 | 31,24k | Derivative Exercise and Sale | 241,12 | 561,00 | - |
| 2026-02-20 | Mr. Charles WitherspoonVP & Treasurer | 38,15 | 0,00 | Derivative Exercise and Retained Stock | - | 1,41k | 2,79% |
| 2026-02-20 | Mr. Charles WitherspoonVP & Treasurer | -22,07 | 5,32k | Derivative Exercise and Sale | 241,12 | 1,41k | - |
| 2026-02-20 | Mr. Chad R. WintersVP of Finance & CAO | 59,14 | 0,00 | Derivative Exercise and Retained Stock | - | 1,52k | 4,04% |
| 2026-02-20 | Mr. Chad R. WintersVP of Finance & CAO | -30,18 | 7,28k | Derivative Exercise and Sale | 241,12 | 1,52k | - |
| 2026-02-18 | Mr. Rudy J. PoussotSVP of Strategy & Corporate Development | 54,49 | 0,00 | Derivative Exercise and Retained Stock | - | 307,00 | 21,58% |
| 2026-02-18 | Mr. Rudy J. PoussotSVP of Strategy & Corporate Development | -27,81 | 6,90k | Derivative Exercise and Sale | 248,26 | 307,00 | - |
| 2026-02-17 | Mr. Charles WitherspoonVP & Treasurer | -41,52 | 10,10k | Sale to Issuer | 243,19 | 1,37k | -2,94% |
| 2026-02-17 | Mr. Chad R. WintersVP of Finance & CAO | -50,58 | 12,30k | Sale to Issuer | 243,19 | 1,46k | -3,34% |
| 2026-02-18 | Mr. Eric M. GreenNon-Independent Chair of the Board, President & CEO | 745,26 | 0,00 | Derivative Exercise and Retained Stock | - | 175,16k | 0,43% |
| 2026-02-18 | Mr. Eric M. GreenNon-Independent Chair of the Board, President & CEO | -573,55 | 142,39k | Derivative Exercise and Sale | 248,26 | 175,16k | - |
| 2026-02-17 | Mr. Eric M. GreenNon-Independent Chair of the Board, President & CEO | -1,31k | 317,46k | Sale to Issuer | 243,19 | 175,16k | -0,74% |
| 2026-02-18 | Ms. Annette F. FavoriteChief HR Officer & Senior VP | 99,73 | 0,00 | Derivative Exercise and Retained Stock | - | 17,37k | 0,58% |
| 2026-02-18 | Ms. Annette F. FavoriteChief HR Officer & Senior VP | -35,76 | 8,88k | Derivative Exercise and Sale | 248,26 | 17,37k | - |
| 2026-02-17 | Ms. Annette F. FavoriteChief HR Officer & Senior VP | -150,44 | 36,59k | Sale to Issuer | 243,19 | 17,37k | -0,86% |
| 2026-02-11 | Mr. Robert W. McMahonSenior VP & CFO | 2,98k | 0,00 | Derivative Exercise and Retained Stock | - | 2,98k | - |
| 2026-02-11 | Mr. Robert W. McMahonSenior VP & CFO | -1,25k | 307,71k | Derivative Exercise and Sale | 246,16 | 2,98k | - |
Les dernières valeurs consultées apparaîtront dans cette boîte, vous permettant de choisir facilement les titres vus auparavant.
Assistance: support@advfn.fr
En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales
S'inscrire avec l'e-mail
Vous avez déjà un compte? Connexion
Vous n'avez pas de compte ? Inscription
En m'inscrivant, je confirme avoir lu, compris et accepté les Conditions générales d'ADVFN et j'affirme etre un investisseur privé.
